Literature DB >> 16863903

Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice.

Ayelet Dar1, Orit Kollet, Tsvee Lapidot.   

Abstract

The chemokine SDF-1 (CXCL12) and its receptor CXCR4 are involved in regulation of migration, survival, and development of multiple cell types, including human hematopoietic CD34+/CD38-/low and stromal STRO-1+ stem cells. During steady-state homeostasis, CXCR4 is expressed by hematopoietic cells and also by stromal cells, which are the main source for SDF-1 in the bone marrow (BM). Stress-induced modulations in SDF-1 and CXCR4 levels participate in recruitment of immature and maturing leukocytes from the BM reservoir to damaged organs as part of host defense and repair mechanism. In addition, trafficking of SDF-1 is mediated by CXCR4, expressed by endothelial and various stromal cell types in the BM, spleen, and other organs, but not by hematopoietic cells. Transcytosis of functional SDF-1 to the BM takes place also in the stem cell-rich endothelium and endosteum regions, regulating hematopoietic and stromal interactions in the stem cell niche. Dynamic levels of SDF-1 and CXCR4 expression induce proliferation of hematopoietic and mesenchymal progenitors, recruitment of bone-resorbing osteoclasts, osteoblasts, neutrophils, and other myeloid cells, leading to leukocyte mobilization. These studies will be reviewed together with the mechanisms that regulate SDF-1 and CXCR4 physiologic function, inactivation, presentation, and availability. Moreover, the role and the dynamic modulations of this ligand and its receptor in alarm and pathologic conditions will be discussed as well.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16863903     DOI: 10.1016/j.exphem.2006.04.002

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  143 in total

1.  Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.

Authors:  Wei Zhu; Gang Liang; Zhiping Huang; Stephen B Doty; Adele L Boskey
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Processing of CXCL12 by different osteoblast-secreted cathepsins.

Authors:  Nicole D Staudt; Andreas Maurer; Bärbel Spring; Hubert Kalbacher; Wilhelm K Aicher; Gerd Klein
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

Review 3.  Cell-based therapy for stroke.

Authors:  Yu Luo
Journal:  J Neural Transm (Vienna)       Date:  2010-10-14       Impact factor: 3.575

4.  Turning CD34 Non-Mobilizers into Mobilizers: A Case Report Involving Plerixafor (AMD3100).

Authors:  Henk S P Garritsen; Thomas Gabrysiak; Andreas Sputtek; Bettina Biermann; Bernhard Wörmann
Journal:  Transfus Med Hemother       Date:  2009-09-10       Impact factor: 3.747

5.  Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro.

Authors:  Samuel Herberg; Sadanand Fulzele; Nianlan Yang; Xingming Shi; Matthew Hess; Sudharsan Periyasamy-Thandavan; Mark W Hamrick; Carlos M Isales; William D Hill
Journal:  Tissue Eng Part A       Date:  2012-08-21       Impact factor: 3.845

Review 6.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

Review 7.  CXCL12 signaling in the development of the nervous system.

Authors:  Divakar S Mithal; Ghazal Banisadr; Richard J Miller
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-21       Impact factor: 4.147

8.  S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release.

Authors:  Karin Golan; Yaron Vagima; Aya Ludin; Tomer Itkin; Shiri Cohen-Gur; Alexander Kalinkovich; Orit Kollet; Chihwa Kim; Amir Schajnovitz; Yossi Ovadya; Kfir Lapid; Shoham Shivtiel; Andrew J Morris; Mariusz Z Ratajczak; Tsvee Lapidot
Journal:  Blood       Date:  2012-01-25       Impact factor: 22.113

9.  Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment.

Authors:  Jinyun Yuan; Jianbin Wang; Karen Crain; Colleen Fearns; Kenneth A Kim; Kevin L Hua; Philip D Gregory; Michael C Holmes; Bruce E Torbett
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

Review 10.  The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion.

Authors:  Peter Neth; Christian Ries; Marisa Karow; Virginia Egea; Matthias Ilmer; Marianne Jochum
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.